Mark Labow

9.3k total citations · 1 hit paper
59 papers, 6.1k citations indexed

About

Mark Labow is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Mark Labow has authored 59 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 20 papers in Immunology and 12 papers in Genetics. Recurrent topics in Mark Labow's work include Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (9 papers) and Cell Adhesion Molecules Research (9 papers). Mark Labow is often cited by papers focused on Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (9 papers) and Cell Adhesion Molecules Research (9 papers). Mark Labow collaborates with scholars based in United States, Switzerland and Germany. Mark Labow's co-authors include Lia Kwee, Kenneth I. Berns, R Chizzonite, Paul L. Hermonat, Perla Nunes, G Ju, Colin L. Stewart, H. Scott Baldwin, Scott Greenfeder and Kim W. McIntyre and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Mark Labow

58 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex

1995 506 citations Lia Kwee, Mark Labow et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Labow United States	37	3.3k	1.7k	1.1k	736	609	59	6.1k
Michael Doyle United States	28	3.2k 1.0×	1.2k 0.7×	700 0.6×	665 0.9×	455 0.7×	41	5.8k
Jack Fransen Netherlands	40	3.2k 1.0×	1.4k 0.8×	831 0.7×	548 0.7×	356 0.6×	133	6.1k
Dhavalkumar D. Patel United States	42	2.3k 0.7×	3.0k 1.8×	1.2k 1.0×	795 1.1×	281 0.5×	67	6.7k
Robert E. Gallagher United States	36	5.0k 1.5×	1.6k 1.0×	1.0k 0.9×	1.1k 1.5×	268 0.4×	98	7.8k
Gary Peltz United States	44	2.7k 0.8×	1.8k 1.1×	885 0.8×	912 1.2×	256 0.4×	144	6.9k
Stephen M. Robbins Canada	44	2.9k 0.9×	2.3k 1.4×	403 0.4×	760 1.0×	477 0.8×	90	6.1k
Bruno Luckow Germany	33	2.5k 0.8×	2.4k 1.4×	880 0.8×	1.4k 1.9×	278 0.5×	57	5.9k
Miguel A. Alonso Spain	47	3.2k 1.0×	1.2k 0.7×	463 0.4×	795 1.1×	286 0.5×	155	6.2k
Richard N. Harkins United States	30	3.8k 1.1×	1.2k 0.7×	1.2k 1.1×	1.3k 1.8×	332 0.5×	58	7.4k
Patrice Dubreuil France	56	2.8k 0.8×	3.4k 2.1×	744 0.7×	1.3k 1.8×	651 1.1×	225	8.8k

Countries citing papers authored by Mark Labow

Since Specialization

Citations

This map shows the geographic impact of Mark Labow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Labow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Labow more than expected).

Fields of papers citing papers by Mark Labow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Labow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Labow. The network helps show where Mark Labow may publish in the future.

Co-authorship network of co-authors of Mark Labow

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Labow. A scholar is included among the top collaborators of Mark Labow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Labow. Mark Labow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilson, Stephen C., et al.. (2022). A novel high-throughput screening strategy for targeting alpha-synuclein and other long-lived proteins. SLAS DISCOVERY. 27(6). 349–357. 6 indexed citations

Bittinger, Mark, Zhaohui Xiong, Somnath Bandyopadhyay, et al.. (2015). TMEM203 Is a Novel Regulator of Intracellular Calcium Homeostasis and Is Required for Spermatogenesis. PLoS ONE. 10(5). e0127480–e0127480. 24 indexed citations

Nicholson, Thomas B., Anup K. Singh, Hui Su, et al.. (2013). A Hypomorphic Lsd1 Allele Results in Heart Development Defects in Mice. PLoS ONE. 8(4). e60913–e60913. 16 indexed citations

Chen, Jian, Qiong Shen, Mark Labow, & L. Alex Gaither. (2011). Protein Kinase D3 Sensitizes RAF Inhibitor RAF265 in Melanoma Cells by Preventing Reactivation of MAPK Signaling. Cancer Research. 71(12). 4280–4291. 19 indexed citations

Gaither, Alex, Dale Porter, Yao Yao, et al.. (2007). A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-α Signaling. Cancer Research. 67(24). 11493–11498. 178 indexed citations

Young, Daniel, Andreas Bender, J.D. Hoyt, et al.. (2007). Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nature Chemical Biology. 4(1). 59–68. 266 indexed citations

Kwee, Lia, Daniel K. Burns, John M. Rumberger, et al.. (2007). Creation and Characterization of E‐Selectin‐ and VCAM‐1‐Deficient Mice. Novartis Foundation symposium. 189. 17–34. 5 indexed citations

Wu, Zhidan, Xueming Huang, Yajun Feng, et al.. (2006). Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1α transcription and mitochondrial biogenesis in muscle cells. Proceedings of the National Academy of Sciences. 103(39). 14379–14384. 249 indexed citations

Daouti, Sherif, Sujatha Nagulapalli, F Buxton, et al.. (2005). Development of comprehensive functional genomic screens to identify novel mediators of osteoarthritis. Osteoarthritis and Cartilage. 13(6). 508–518. 40 indexed citations

10.

Bittinger, Mark, Elizabeth McWhinnie, Jodi Meltzer, et al.. (2004). Activation of cAMP Response Element-Mediated Gene Expression by Regulated Nuclear Transport of TORC Proteins. Current Biology. 14(23). 2156–2161. 194 indexed citations

11.

Mickanin, Craig, Umesh Bhatia, & Mark Labow. (2001). Identification of a novel β-chemokine, MEC, down-regulated in primary breast tumors. International Journal of Oncology. 18(5). 939–44. 14 indexed citations

12.

Josephs, Michael D., Carmen C. Solórzano, Jason J. Rosenberg, et al.. (2000). Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1ra. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 278(4). R824–R830. 31 indexed citations

13.

Labow, Mark, David J. Shuster, Maria Zetterström, et al.. (1997). Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. The Journal of Immunology. 159(5). 2452–2461. 286 indexed citations

14.

Braun, Andrea, Lia Kwee, Mark Labow, & Jochem Alsenz. (1997). Protein Aggregates Seem to Play a Key Role Among the Parameters Influencing the Antigenicity of Interferon Alpha (IFN-α) in Normal and Transgenic Mice. Pharmaceutical Research. 14(10). 1472–1478. 244 indexed citations

15.

Labow, Mark. (1995). [24] Use of lac activator proteins for regulated expression of oncogenes. Methods in enzymology on CD-ROM/Methods in enzymology. 254. 375–387. 3 indexed citations

16.

Pirozzi, Gianluca, Robert W. Terry, Douglas J. Epstein, & Mark Labow. (1995). Identification and characterization of a novel surface antigen gene induced in mast cells activated through the high affinity IgE receptor. The Journal of Immunology. 155(12). 5811–5818. 3 indexed citations

17.

Terry, Robert W., et al.. (1993). Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein.. Proceedings of the National Academy of Sciences. 90(13). 5919–5923. 65 indexed citations

18.

Zambetti, Gerard P., Dan Olson, Mark Labow, & Arnold J. Levine. (1992). A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.. Proceedings of the National Academy of Sciences. 89(9). 3952–3956. 50 indexed citations

19.

Labow, Mark, et al.. (1990). Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells.. Molecular and Cellular Biology. 10(7). 3343–3356. 52 indexed citations

20.

Labow, Mark & Kenneth I. Berns. (1988). The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. Journal of Virology. 62(5). 1705–1712. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact